GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $379,000 | +0.8% | 8,703 | +1.0% | 0.06% | +16.0% |
| Q1 2022 | $376,000 | -8.7% | 8,618 | -7.7% | 0.05% | -5.7% |
| Q4 2021 | $412,000 | +7.6% | 9,338 | -7.0% | 0.05% | 0.0% |
| Q3 2021 | $383,000 | -7.5% | 10,038 | -3.5% | 0.05% | -7.0% |
| Q2 2021 | $414,000 | +10.1% | 10,400 | -1.2% | 0.06% | +5.6% |
| Q1 2021 | $376,000 | -17.9% | 10,530 | -15.5% | 0.05% | -22.9% |
| Q4 2020 | $458,000 | -2.6% | 12,463 | 0.0% | 0.07% | -10.3% |
| Q3 2020 | $470,000 | -8.9% | 12,463 | -1.4% | 0.08% | -15.2% |
| Q2 2020 | $516,000 | +7.9% | 12,638 | 0.0% | 0.09% | -6.1% |
| Q1 2020 | $478,000 | -25.4% | 12,638 | -7.3% | 0.10% | -3.0% |
| Q4 2019 | $641,000 | +10.1% | 13,638 | 0.0% | 0.10% | -1.0% |
| Q3 2019 | $582,000 | -3.0% | 13,638 | -9.0% | 0.10% | -4.7% |
| Q2 2019 | $600,000 | -4.9% | 14,991 | -0.7% | 0.11% | -7.0% |
| Q1 2019 | $631,000 | +2.6% | 15,091 | -6.2% | 0.12% | +16.2% |
| Q4 2018 | $615,000 | -14.3% | 16,091 | -10.0% | 0.10% | -14.7% |
| Q3 2018 | $718,000 | -2.3% | 17,883 | -2.0% | 0.12% | -12.1% |
| Q2 2018 | $735,000 | +1.1% | 18,243 | -1.9% | 0.13% | +10.9% |
| Q1 2018 | $727,000 | -0.7% | 18,605 | -9.9% | 0.12% | +3.5% |
| Q4 2017 | $732,000 | -14.8% | 20,651 | -2.4% | 0.12% | -16.1% |
| Q3 2017 | $859,000 | -10.7% | 21,153 | -5.2% | 0.14% | -12.7% |
| Q2 2017 | $962,000 | -6.3% | 22,305 | -8.5% | 0.16% | -7.6% |
| Q1 2017 | $1,027,000 | +2.3% | 24,373 | -6.5% | 0.17% | -1.7% |
| Q4 2016 | $1,004,000 | -13.7% | 26,063 | -3.5% | 0.17% | -14.8% |
| Q3 2016 | $1,164,000 | +5.8% | 26,996 | +6.4% | 0.20% | +5.7% |
| Q2 2016 | $1,100,000 | +12.8% | 25,372 | +5.6% | 0.19% | +12.3% |
| Q1 2016 | $975,000 | +1.6% | 24,028 | +1.0% | 0.17% | -0.6% |
| Q4 2015 | $960,000 | +3.2% | 23,797 | -1.6% | 0.17% | -1.1% |
| Q3 2015 | $930,000 | -33.5% | 24,192 | -28.0% | 0.17% | -23.7% |
| Q2 2015 | $1,399,000 | -10.9% | 33,588 | -1.3% | 0.23% | -8.8% |
| Q1 2015 | $1,570,000 | +3.8% | 34,027 | -3.9% | 0.25% | +5.5% |
| Q4 2014 | $1,513,000 | -5.6% | 35,412 | +1.6% | 0.24% | -7.8% |
| Q3 2014 | $1,602,000 | -13.7% | 34,842 | +0.4% | 0.26% | -8.9% |
| Q2 2014 | $1,856,000 | -1.6% | 34,698 | -1.7% | 0.28% | +2.9% |
| Q1 2014 | $1,886,000 | -0.9% | 35,307 | -1.0% | 0.27% | +0.4% |
| Q4 2013 | $1,904,000 | -3.1% | 35,668 | -8.9% | 0.27% | -6.8% |
| Q3 2013 | $1,965,000 | -4.8% | 39,166 | -5.2% | 0.29% | -5.5% |
| Q2 2013 | $2,064,000 | – | 41,311 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |